These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 1807227)
101. Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy. Leport C; Raffi F; Matheron S; Katlama C; Regnier B; Saimot AG; Marche C; Vedrenne C; Vilde JL Am J Med; 1988 Jan; 84(1):94-100. PubMed ID: 3337134 [TBL] [Abstract][Full Text] [Related]
102. Comparison of two medications in central nervous system toxoplasmosis in patients with AIDS. Antinori A; Ammassari A; Maiuro G; Camilli G; Damiano F; Federico G; Pizzigallo E; Tamburrini E Ital J Neurol Sci; 1992 Sep; 13(6):475-9. PubMed ID: 1428784 [TBL] [Abstract][Full Text] [Related]
103. Role of clindamycin in the treatment of central nervous system toxoplasmosis. Rolston KV; Hoy J Am J Med; 1987 Sep; 83(3):551-4. PubMed ID: 3661590 [TBL] [Abstract][Full Text] [Related]
104. [Treatment of neurotoxoplasmosis with the combination sulfamethoxazole-trimethoprim: report of 10 cases]. Nóbrega JP Arq Neuropsiquiatr; 1991 Sep; 49(3):279-84. PubMed ID: 1807227 [TBL] [Abstract][Full Text] [Related]
105. [The characteristics of the opportunistic infections associated with AIDS: tuberculosis and toxoplasmosis]. Gatell JM Rev Clin Esp; 1990 May; 186(8):405-6. PubMed ID: 2236772 [No Abstract] [Full Text] [Related]
106. Toxoplasmosis in AIDS patients. Tuazon CU J Antimicrob Chemother; 1989 Jan; 23 Suppl A():77-82. PubMed ID: 2654118 [TBL] [Abstract][Full Text] [Related]
108. Toxoplasmosis in immunosuppression and AIDS. Velimirovic B Infection; 1984; 12(5):315-7. PubMed ID: 6392101 [TBL] [Abstract][Full Text] [Related]
109. [Usefulness of folinic acid in cytopenia induced by antiparasitic drugs in AIDS patients]. Niyongabo T; Leport C; Vildé JL Presse Med; 1991 Oct; 20(34):1677-81. PubMed ID: 1836573 [TBL] [Abstract][Full Text] [Related]
110. Therapeutic approaches for AIDS-related toxoplasmosis. Behbahani R; Moshfeghi M; Baxter JD Ann Pharmacother; 1995; 29(7-8):760-8. PubMed ID: 8520094 [TBL] [Abstract][Full Text] [Related]
111. Toxoplasmosis and the acquired immune deficiency syndrome. Holliman RE J Infect; 1988 Mar; 16(2):121-8. PubMed ID: 3280690 [TBL] [Abstract][Full Text] [Related]
112. [Toxoplasmosis in immunocompromised patients]. Machala L; Kodym P; Malý M; Geleneky M; Beran O; Jilich D Epidemiol Mikrobiol Imunol; 2015 Jun; 64(2):59-65. PubMed ID: 26099608 [TBL] [Abstract][Full Text] [Related]
113. How AIDS attacks the brain. Scherer P Am J Nurs; 1990 Jan; 90(1):44-52. PubMed ID: 2153341 [No Abstract] [Full Text] [Related]
114. A systematic review and meta-analysis of the relative efficacy and safety of treatment regimens for HIV-associated cerebral toxoplasmosis: is trimethoprim-sulfamethoxazole a real option? Hernandez AV; Thota P; Pellegrino D; Pasupuleti V; Benites-Zapata VA; Deshpande A; Penalva de Oliveira AC; Vidal JE HIV Med; 2017 Feb; 18(2):115-124. PubMed ID: 27353303 [TBL] [Abstract][Full Text] [Related]
115. Prophylaxis of AIDS-related opportunistic infections (OIs). Current status and future strategies. Hardy WD AIDS Clin Rev; 1991; ():145-80. PubMed ID: 1651099 [No Abstract] [Full Text] [Related]
116. [Toxoplasmosis: new aspects, diagnosis and treatment]. Oksenhendler E; Matheron S Rev Prat; 1992 Jan; 42(2):155-9. PubMed ID: 1565998 [TBL] [Abstract][Full Text] [Related]